Research Article
Prognostic Significance of Substance P/Neurokinin 1 Receptor and Its Association with Hormonal Receptors in Breast Carcinoma
Table 5
Expression and scoring of ER, PR, and HER2 in SP-positive breast cancer cases.
| SP-positive cases () | Age (years) | Grade | Histoopinion | SP expression | score | Expression | % of cell stain | Intensity of stain | Allred score | Expression | % of cell stain | Intensity of stain | Allred score | Expression | TNM | Size (cm) | | ER status | PR status | HER2 status |
| 33 | 2 | IDC | +++ | 140 | − | − | − | − | − | − | − | − | ++ | PT2 | <2 | 58 | 3 | IDC=DCIS | +++ | 190 | +++ | 5 | 3 | 8 | +++ | 5 | 3 | 8 | +++ | PT4 | 2-5 | 57 | 3 | IDC | +++ | 240 | +++ | 5 | 3 | 8 | +++ | 5 | 3 | 8 | +++ | PT2 | 2-5 | 34 | 3 | IDC | +++ | 240 | + | 2 | 2 | 4 | ++ | 4 | 2 | 6 | − | PT2 | <2 | 50 | 3 | IDC+DCIS | +++ | 150 | +++ | 5 | 3 | 8 | ++ | 4 | 2 | 6 | ++ | PT4b | 2-5 | 62 | 3 | IDC+DCIS | ++ | 120 | + | 2 | 3 | 5 | ++ | − | − | 6 | ++ | PT2 | 2-5 | 54 | 3 | IDC | +++ | 210 | +++ | 5 | 3 | 8 | +++ | 5 | 3 | 8 | +++ | PT2 | 2-5 | 33 | 2 | IDC | ++ | 160 | +++ | 5 | 3 | 8 | ++ | 4 | 3 | 7 | ++ | PT2 | 2-5 | 37 | 3 | IDC+DCIS | +++ | 210 | ++ | 4 | 2 | 6 | +++ | 5 | 3 | 8 | +++ | PT1c | >5 | 67 | 2 | IDC+E-DCIS | + | 140 | + | 3 | 1 | 4 | − | + | − | − | − | PT3 | 2-5 | 63 | 1 | DCIS | + | 60 | + | 2 | 2 | 4 | ++ | 3 | 3 | 6 | − | PT1 | >5 | 32 | 3 | IDC | + | 180 | +++ | 5 | 3 | 8 | +++ | 5 | 3 | 8 | +++ | PT2 | <2 | 33 | 3 | IDC | + | 70 | + | 3 | 2 | 5 | ++ | 3 | 3 | 6 | − | PT2 | 2-5 | 42 | 2 | ILC | + | 150 | +++ | 5 | 3 | 8 | ++ | 4 | 3 | 7 | ++ | PT2 | >5 | 57 | 3 | IDC | ++ | 140 | − | − | − | − | − | − | − | − | ++ | PT2 | 2-5 | 37 | 3 | IDC | ++ | 150 | − | − | − | − | − | − | − | − | + | PT2 | 2-5 | 47 | 2 | IDC | ++ | 180 | + | 3 | 1 | 4 | − | + | − | 3 | + | PT2 | 2-5 | 34 | 3 | IDC | +++ | 160 | + | 2 | 2 | 4 | + | 3 | 1 | 4 | − | PT1 | >5 | 50 | 3 | IDC | +++ | 210 | + | 2 | 2 | 4 | ++ | 5 | 2 | 7 | ++ | PT3 | 2-5 | 67 | 1 | IDC | + | 160 | +++ | 5 | 3 | 8 | ++ | 4 | 3 | 7 | ++ | PT2 | 2-5 | 42 | 3 | IDC | +++ | 240 | +++ | 5 | 3 | 8 | ++ | 4 | 3 | 7 | ++ | PT1c | >5 | 32 | 2 | ILC | ++ | 180 | +++ | 5 | 3 | 8 | +++ | 5 | 3 | 8 | ++ | PT2 | 2-5 | 50 | 2 | IDC | ++ | 160 | − | − | − | − | − | − | − | − | + | PT2 | 2-5 |
|
|